Prof. Dr. MELİH ÖNDER BABAOĞLU

Yayın Ağı

Makaleler 10

1. Association of Endothelial Nitric Oxide Synthase Polymorphisms with Clinical Severity in Patients with COVID-19

Idikut A., DEĞER İ., Goektas G., KARAHAN S., SARINÇ S., KÖKSAL D., et al.

JOURNAL OF CLINICAL MEDICINE , cilt.14, sa.6, 2025 (SCI-Expanded, Scopus)

2. Association of Genetic Polymorphisms of Multidrug Resistance Protein (MDR) with Clinical Outcomes in Colchicine Intoxication

UYSAL YAZICI M., BABAOĞLU M. Ö., MÜDERRİSOĞLU A., BAYRAKCİ B.

EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY , cilt.8, sa.4, ss.443-449, 2024 (ESCI, Scopus, TRDizin)

3. Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions

van der Horst M. Z., Meijer Y., de Boer N., Guloksuz S., Hasan A., Siskind D., et al.

Psychiatry Research , cilt.330, 2023 (SCI-Expanded, SSCI, Scopus)

4. Effects of genetic polymorphisms of CYP2J2, CYP2C9, CYP2C19, CYP4F2, CYP4F3 and CYP4A11 enzymes in preeclampsia and gestational hypertension

Ongun M. C., Tonyali N. V., KAPLAN O., DEĞER İ., ÇELEBİER M., BAŞCI AKDUMAN N. E., et al.

Placenta , cilt.137, ss.88-95, 2023 (SCI-Expanded, Scopus)

5. Para-aminosalicylic acid significantly reduced tenofovir exposure in human subjects: Mismatched findings from in vitro to in vivo translational research

Parvez M. M., Kalkisim S., Nguyen P. T. T., Jung J. A., Park J., Ghim J., et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , cilt.88, sa.3, ss.1159-1169, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

6. Comparative Assessment of Outcomes in Drug Treatment for Smoking Cessation and Role of Genetic Polymorphisms of Human Nicotinic Acetylcholine Receptor Subunits

MÜDERRİSOĞLU A., BABAOĞLU E., KORKMAZ E. T., Kalkisim S., KARABULUT E., Emri S., et al.

FRONTIERS IN GENETICS , cilt.13, 2022 (SCI-Expanded, Scopus)

7. Endothelial nitric oxide synthase G894T, intron 4 VNTR, and T786C polymorphisms in retinopathy of prematurity

Tekkeşin F., Yurdakok M., GÜMÜŞ E., BABAOĞLU M. Ö., Bozkurt A., Caliskan Kadayifcilar S., et al.

Journal of Neonatal-Perinatal Medicine , cilt.15, sa.2, ss.249-255, 2022 (Scopus)

8. The effect of CYP2C9 gene polymorphisms on blood pressure lowering response to losartan in patients with essential hypertension

Tanrikulu F. P., BABAOĞLU M. Ö., ÇAKIR B., BOZKURT A., Guven G. S.

CUKUROVA MEDICAL JOURNAL , cilt.47, sa.3, ss.1015-1023, 2022 (ESCI, TRDizin)

9. Effects of Cytochrome p450 (CYP) 2C19 Genetic Polymorphisms on Voriconazole Serum Levels: A Report of Two Cases

TAŞ Z., KARA E., DEĞER O., İspirli M., METAN G., BABAOĞLU M. Ö., et al.

Mediterranean Journal of Infection, Microbes and Antimicrobials , cilt.10, 2021 (Scopus)

10. Effects of Genetic Polymorphisms of Drug Transporter ABCB1 (MDR1) and Cytochrome P450 Enzymes CYP2A6, CYP2B6 on Nicotine Addiction and Smoking Cessation

Muderrisoglu A., BABAOĞLU E., Korkmaz E. T., Ongun M. C., KARABULUT E., İSKİT A. B., et al.

FRONTIERS IN GENETICS , cilt.11, 2020 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 2

1. ABCB1 C3435T genetic polymorphism alters clinical response to losartan in patients with hypertension

GÖKTAŞ M. T., PEPEDİL F., SAİN GÜVEN G., ÇAKIR B., BABAOĞLU M. Ö., YAŞAR Ü., et al.

16th World Congress of Basic and Clinical Pharmacology, KOPENHAG, Danimarka, 17 - 23 Temmuz 2010, cilt.107, ss.162-692

2. Yeni tanı almış hipertansiyon hastalarında CYP2C9 genetik polimorfizminin değerlendirilmesi

GÖKTAŞ M. T., PEPEDİL F., SAİN GÜVEN G., ÇAKIR B., BABAOĞLU M. Ö., YAŞAR Ü., et al.

Türk Farmakoloji Derneği 20.Ulusal Farmakoloji Kongresi, Türkiye, 4 - 07 Kasım 2009

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

181

H-İndeks (WoS)

Atıf (Scopus)

216

H-İndeks (Scopus)

Proje

Tez Danışmanlığı

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler